Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Milk thistle: a future potential anti-osteoporotic and fracture healing agent.

Mohd Fozi NF, Mazlan M, Shuid AN, Isa Naina M.

Curr Drug Targets. 2013 Dec;14(14):1659-66. Review.

PMID:
24093748
2.

Osteoporotic fracture healing: potential use of medicinal plants from the tropics.

Abdul Jalil MA, Shuid AN, Muhammad N.

Curr Drug Targets. 2013 Dec;14(14):1651-8. Review.

PMID:
24354586
3.

Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.

El-Shitany NA, Hegazy S, El-Desoky K.

Phytomedicine. 2010 Feb;17(2):116-25. doi: 10.1016/j.phymed.2009.05.012. Epub 2009 Jul 3.

PMID:
19577454
4.

Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.

Kim JL, Park SH, Jeong D, Nam JS, Kang YH.

Exp Biol Med (Maywood). 2012 Apr;237(4):417-28. doi: 10.1258/ebm.2011.011376. Epub 2012 Apr 10.

PMID:
22496431
5.

Experimental fracture protocols in assessments of potential agents for osteoporotic fracture healing using rodent models.

Ibrahim N', Mohamad S, Mohamed N, Shuid AN.

Curr Drug Targets. 2013 Dec;14(14):1642-50. Review.

PMID:
24350807
6.

Effects of black cohosh (Cimicifuga racemosa) and estrogen on metaphyseal fracture healing in the early stage of osteoporosis in ovariectomized rats.

Kolios L, Schumann J, Sehmisch S, Rack T, Tezval M, Seidlova-Wuttke D, Frosch KH, Stuermer KM, Stuermer EK.

Planta Med. 2010 Jun;76(9):850-7. doi: 10.1055/s-0029-1240798. Epub 2010 Jan 26.

PMID:
20104444
7.

Effects of α-tocopherol on the early phase of osteoporotic fracture healing.

Shuid AN, Mohamad S, Muhammad N, Fadzilah FM, Mokhtar SA, Mohamed N, Soelaiman IN.

J Orthop Res. 2011 Nov;29(11):1732-8. doi: 10.1002/jor.21452. Epub 2011 May 5.

8.

Piper sarmentosum: a new hope for the treatment of osteoporosis.

Mohd Ramli ES, Suhaimi F, Ahmad F, Shuid AN, Mohamad N, Ima-Nirwana S.

Curr Drug Targets. 2013 Dec;14(14):1675-82. Review.

PMID:
24107234
9.

Equol but not genistein improves early metaphyseal fracture healing in osteoporotic rats.

Kolios L, Sehmisch S, Daub F, Rack T, Tezval M, Stuermer KM, Stuermer EK.

Planta Med. 2009 Apr;75(5):459-65. doi: 10.1055/s-0029-1185380. Epub 2009 Feb 24.

PMID:
19241330
10.

Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper.

Goldhahn J, Féron JM, Kanis J, Papapoulos S, Reginster JY, Rizzoli R, Dere W, Mitlak B, Tsouderos Y, Boonen S.

Calcif Tissue Int. 2012 May;90(5):343-53. doi: 10.1007/s00223-012-9587-4. Epub 2012 Mar 28.

PMID:
22451221
11.

A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.

Tarantino U, Celi M, Feola M, Liuni FM, Resmini G, Iolascon G.

Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S65-9. doi: 10.1007/s40520-013-0082-1. Epub 2013 Sep 18. Review.

PMID:
24046047
12.

Update on statins: hope for osteoporotic fracture healing treatment.

Ibrahim N', Mohamed N, Shuid AN.

Curr Drug Targets. 2013 Dec;14(13):1524-32. Review.

PMID:
23876090
14.

Parathyroid hormone and bone healing.

Ellegaard M, Jørgensen NR, Schwarz P.

Calcif Tissue Int. 2010 Jul;87(1):1-13. doi: 10.1007/s00223-010-9360-5. Epub 2010 Apr 29. Review.

PMID:
20428858
15.

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.

Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.

Bone. 2004 Apr;34(4):728-35.

PMID:
15050905
16.

Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.

Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.

Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95.

PMID:
15645517
17.

[Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].

Hayakawa N, Suzuki A.

Clin Calcium. 2013 Sep;23(9):1337-44. doi: CliCa130913371344. Review. Japanese.

PMID:
23999371
18.

Milk thistle in liver diseases: past, present, future.

Abenavoli L, Capasso R, Milic N, Capasso F.

Phytother Res. 2010 Oct;24(10):1423-32. doi: 10.1002/ptr.3207. Review.

PMID:
20564545
19.

Pathogenesis, prevention, and treatment of osteoporosis.

Stevenson JC.

Obstet Gynecol. 1990 Apr;75(4 Suppl):36S-41S; discussion 51S-52S. Review.

PMID:
2179789
20.

Prevention and treatment of osteoporosis with hormone replacement therapy.

Christiansen C.

Int J Fertil Menopausal Stud. 1993;38 Suppl 1:45-54. Review.

PMID:
8499959

Supplemental Content

Support Center